Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 Studies
PaperCitations, authors & open-access status
Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 Studies is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 218 citations, 2015 year and bronze oa status.
218
Citations
2015
Year
bronze
OA Status